BIOLASE To Present At The 13th Annual LD Micro Main Event Conference

<br /> BIOLASE To Present At The 13th Annual LD Micro Main Event Conference<br />


FOOTHILL RANCH, Calif.

, Dec. 9, 2020 /PRNewswire/ — BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will be presenting at the 13th annual LD Micro Main Event investor conference on

Monday, December 14

at

9:40 AM PST

/

12:40 PM EST

. President and CEO

Todd Norbe

and Executive Vice President, CFO and COO

John Beaver

will be presenting to a live, virtual audience.


Register to attend the event here:


ve.mysequire.com/


The Main Event will feature a new and unique format, with companies presenting for 10 minutes, followed by 10 minutes of Q&A by a panel of investors and analysts.

“The time has finally come to do something different in the virtual conference world. Let’s see if we can pull off something that can be enjoyed by both executives and investors alike,” stated

Chris Lahiji

, Founder of LD, now a wholly owned subsidiary of SRAX, Inc.

The Main Event will take place on

December 14th

and 15th, exclusively on the Sequire Virtual Events platform.


View BIOLASE’s profile here:

http://www.ldmicro.com/profile/BIOL

Profiles powered

by LD Micro

.


About BIOLASE, Inc.

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine.  BIOLASE’s products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE’s proprietary laser products incorporate approximately 259 patented and 41 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times.  BIOLASE’s innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients.  BIOLASE’s principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications.  BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world.  Laser products under development address BIOLASE’s core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus

®

, Waterlase Express



, and laser dentistry, find BIOLASE online at

www.biolase.com

, Facebook at

www.facebook.com/biolase

, Twitter at

www.twitter.com/biolaseinc

, Instagram at

www.instagram.com/waterlase_laserdentistry

, and LinkedIn at

www.linkedin.com/company/biolase

.

BIOLASE

®

, Waterlase

®

and Waterlase iPlus

®

are registered trademarks of BIOLASE, Inc.


About LD Micro/SEQUIRE

LD Micro began in 2006 with the sole purpose of being an independent resource to the microcap world. What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space. For more information, please visit


ldmicro.com


.

The upcoming Main Event will be highlighting a new format that will benefit both executives and the investors tuning in from all over the globe.

In

September 2020

, LD Micro. Inc. was acquired by SRAX, Inc., a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform,


Sequire


, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX, visit


srax.com


and


mysequire.com


.

Cision
View original content to download multimedia:

http://www.prnewswire.com/news-releases/biolase-to-present-at-the-13th-annual-ld-micro-main-event-conference-301189336.html

SOURCE BIOLASE, Inc.